In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation

Bao Chen1,2, Zhouhua Wang1, Guilan Quan1, Xinsheng Peng1, Xin Pan1, Rongchang Wang1, Yuehong Xu1, Ge Li2, Chuanbin Wu1,21School of Pharmaceutical Sciences, 2Research and Development Center of Pharmaceutical Engineering, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaBackg...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xu Y, Wang R, Pan X, Peng X, Quan G, Wang Z, Chen B, Li G, Wu C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/70b67a61a99440ffb41481d97c586617
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:70b67a61a99440ffb41481d97c586617
record_format dspace
spelling oai:doaj.org-article:70b67a61a99440ffb41481d97c5866172021-12-02T00:36:57ZIn vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation1176-91141178-2013https://doaj.org/article/70b67a61a99440ffb41481d97c5866172012-01-01T00:00:00Zhttp://www.dovepress.com/in-vitro-and-in-vivo-evaluation-of-ordered-mesoporous-silica-as-a-nove-a9065https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Bao Chen1,2, Zhouhua Wang1, Guilan Quan1, Xinsheng Peng1, Xin Pan1, Rongchang Wang1, Yuehong Xu1, Ge Li2, Chuanbin Wu1,21School of Pharmaceutical Sciences, 2Research and Development Center of Pharmaceutical Engineering, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaBackground: A liquisolid technique has been reported to be a new approach to improve the release of poorly water-soluble drugs for oral administration. However, an apparent limitation of this technique is the formulation of a high dose because a large amount of liquid vehicle is needed, which finally results in a low-dose liquisolid formulation. Silica as an absorbent has been used extensively in liquisolid formulations. Although nanoparticle silica can be prepared and used to improve liquid adsorption capacity, loading a high dose of drug into a liquisolid is still a challenge. With the aim of improving adsorption capacity and accordingly achieving high drug loading, ordered mesoporous silica with a high surface area and narrow pore size distribution was synthesized and used in a liquisolid formulation.Methods: Ordered mesoporous silica was synthesized and its particle size and morphology were tailored by controlling the concentration of cetyltrimethyl ammonium bromide. The ordered mesoporous silica synthesized was characterized by transmission electron microscopy, scanning electron microscopy, Fourier transform infrared spectroscopy, small-angle x-ray diffraction, wide angle x-ray diffraction, and nitrogen adsorption-desorption measurements. The liquid adsorption capacity of ordered mesoporous silica was subsequently compared with that of conventional silica materials using PEG400 as the model liquid. Carbamazepine was chosen as a model drug to prepare the liquisolid formulation, with ordered mesoporous silica as the adsorbent material. The preparation was evaluated and compared with commercially available fast-release carbamazepine tablets in vitro and in vivo.Results: Characterization of the ordered mesoporous silica synthesized in this study indicated a huge Brunauer–Emmett–Teller surface area (1030 m2/g), an ordered mesoporous structure with a pore size of 2.8 nm, and high adsorption capacity for liquid compared with conventional silica. Compared with fast-release commercial carbamazepine tablets, drug release from the liquisolid capsules was greatly improved, and the bioavailability of the liquisolid preparation was enhanced by 182.7%.Conclusion: Ordered mesoporous silica is a potentially attractive adsorbent which may lead to a new approach for development of liquisolid products.Keywords: ordered mesoporous silica, poorly water-soluble drug, carbamazepine, liquisolid, bioavailabilityXu YWang RPan XPeng XQuan GWang ZChen BLi GWu CDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 199-209 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Xu Y
Wang R
Pan X
Peng X
Quan G
Wang Z
Chen B
Li G
Wu C
In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation
description Bao Chen1,2, Zhouhua Wang1, Guilan Quan1, Xinsheng Peng1, Xin Pan1, Rongchang Wang1, Yuehong Xu1, Ge Li2, Chuanbin Wu1,21School of Pharmaceutical Sciences, 2Research and Development Center of Pharmaceutical Engineering, Sun Yat-sen University, Guangzhou, People’s Republic of ChinaBackground: A liquisolid technique has been reported to be a new approach to improve the release of poorly water-soluble drugs for oral administration. However, an apparent limitation of this technique is the formulation of a high dose because a large amount of liquid vehicle is needed, which finally results in a low-dose liquisolid formulation. Silica as an absorbent has been used extensively in liquisolid formulations. Although nanoparticle silica can be prepared and used to improve liquid adsorption capacity, loading a high dose of drug into a liquisolid is still a challenge. With the aim of improving adsorption capacity and accordingly achieving high drug loading, ordered mesoporous silica with a high surface area and narrow pore size distribution was synthesized and used in a liquisolid formulation.Methods: Ordered mesoporous silica was synthesized and its particle size and morphology were tailored by controlling the concentration of cetyltrimethyl ammonium bromide. The ordered mesoporous silica synthesized was characterized by transmission electron microscopy, scanning electron microscopy, Fourier transform infrared spectroscopy, small-angle x-ray diffraction, wide angle x-ray diffraction, and nitrogen adsorption-desorption measurements. The liquid adsorption capacity of ordered mesoporous silica was subsequently compared with that of conventional silica materials using PEG400 as the model liquid. Carbamazepine was chosen as a model drug to prepare the liquisolid formulation, with ordered mesoporous silica as the adsorbent material. The preparation was evaluated and compared with commercially available fast-release carbamazepine tablets in vitro and in vivo.Results: Characterization of the ordered mesoporous silica synthesized in this study indicated a huge Brunauer–Emmett–Teller surface area (1030 m2/g), an ordered mesoporous structure with a pore size of 2.8 nm, and high adsorption capacity for liquid compared with conventional silica. Compared with fast-release commercial carbamazepine tablets, drug release from the liquisolid capsules was greatly improved, and the bioavailability of the liquisolid preparation was enhanced by 182.7%.Conclusion: Ordered mesoporous silica is a potentially attractive adsorbent which may lead to a new approach for development of liquisolid products.Keywords: ordered mesoporous silica, poorly water-soluble drug, carbamazepine, liquisolid, bioavailability
format article
author Xu Y
Wang R
Pan X
Peng X
Quan G
Wang Z
Chen B
Li G
Wu C
author_facet Xu Y
Wang R
Pan X
Peng X
Quan G
Wang Z
Chen B
Li G
Wu C
author_sort Xu Y
title In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation
title_short In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation
title_full In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation
title_fullStr In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation
title_full_unstemmed In vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation
title_sort in vitro and in vivo evaluation of ordered mesoporous silica as a novel adsorbent in liquisolid formulation
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/70b67a61a99440ffb41481d97c586617
work_keys_str_mv AT xuy invitroandinvivoevaluationoforderedmesoporoussilicaasanoveladsorbentinliquisolidformulation
AT wangr invitroandinvivoevaluationoforderedmesoporoussilicaasanoveladsorbentinliquisolidformulation
AT panx invitroandinvivoevaluationoforderedmesoporoussilicaasanoveladsorbentinliquisolidformulation
AT pengx invitroandinvivoevaluationoforderedmesoporoussilicaasanoveladsorbentinliquisolidformulation
AT quang invitroandinvivoevaluationoforderedmesoporoussilicaasanoveladsorbentinliquisolidformulation
AT wangz invitroandinvivoevaluationoforderedmesoporoussilicaasanoveladsorbentinliquisolidformulation
AT chenb invitroandinvivoevaluationoforderedmesoporoussilicaasanoveladsorbentinliquisolidformulation
AT lig invitroandinvivoevaluationoforderedmesoporoussilicaasanoveladsorbentinliquisolidformulation
AT wuc invitroandinvivoevaluationoforderedmesoporoussilicaasanoveladsorbentinliquisolidformulation
_version_ 1718403625190948864